18 year outcomes of Childhood Persistent-Wheezers (PW) at 10 years old compared to Non-Wheezers (NW)
| Characteristic | OR | P Value | CI |
| Female Gender | 0.60 | 0.01 | 0.41–0.89 |
| Atopy | 2.78 | <0.001 | 1.69–4.56 |
| Eczema | 2.06 | 0.007 | 1.21–3.50 |
| Rhinitis | 3.05 | <0.001 | 2.01–4.63 |
| Asthma | 19.82 | <0.001 | 11.96–32.82 |
| Wheeze in last 12 months | 10.28 | <0.001 | 6.53–16.20 |
| Smoking at 18 | 2.53 | <0.001 | 1.65–3.87 |
| Ever Smoked | 2.76 | <0.001 | 1.74–4.39 |
| Cumulative Smoke Exposure 1–18 | 2.53 | <0.001 | 1.53–4.18 |
| Wheezy During or After Exercise | 2.04 | 0.012 | 1.17–3.57 |
| Dry Cough At Night | 4.78 | <0.001 | 2.88–7.94 |
| Characteristic | P Value | CI | |
| FEV1 | 0.031 | 0.02–0.40 | |
| FEV1/FVC Ratio | <0.001 | 0.04–0.08 | |
| FEF 25–75% | <0.001 | 0.41–0.95 | |
| FeNO | <0.001 | (-0.38)–(-0.19) | |
| BHR | <0.001 | (-3.23) – (-0.16) | |
| FEF growth in mls 10–18 years | 0.002 | 147.28–624.59 | |
| Bronchodilator Reversibility | <0.001 | (-5.63)–(-2.810) |